IMMUNIC, INC. — Investor Relations & Filings
Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| 10-Q - IMMUNIC, INC. (0001280776) (Filer) | 2026-05-13 | English | |
| Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | 2026-05-13 | English | |
| Immunic to Participate in Investor and Medical Conferences in May | 2026-04-30 | English | |
| 8-K - IMMUNIC, INC. (0001280776) (Filer) | 2026-04-28 | English | |
| Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer | 2026-04-28 | English |
Browse filings by year
22 years- 2026 32 filings
- 2025 75 filings
- 2024 73 filings
- 2023 39 filings
- 2022 66 filings
- 2021 48 filings
- 2020 59 filings
- 2019 78 filings
- 2018 52 filings
- 2017 59 filings
- 2016 46 filings
- 2015 46 filings
- 2014 72 filings
- 2013 22 filings
- 2012 4 filings
- 2011 4 filings
- 2010 5 filings
- 2009 3 filings
- 2007 1 filing
- 2006 1 filing
- 2005 2 filings
- 2004 2 filings
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PegBio Co., Ltd.
Specializes in discovering and developing innovative therap…
|
2565 | HK | Professional, scientific and te… |
|
PELL BIO-MED TECHNOLOGY CO., LTD.
Develops advanced cell and gene therapies, including CAR-T …
|
6949 | TW | Professional, scientific and te… |
|
PepGen Inc.
Develops oligonucleotide therapeutics for neuromuscular and…
|
PEPG | US | Professional, scientific and te… |
|
PERCHERON THERAPEUTICS LIMITED
Clinical-stage developer of antisense pharmaceuticals for r…
|
PER | AU | Professional, scientific and te… |
|
Perseus Proteomics Inc.
Develops antibody-based therapeutics, diagnostics, and rese…
|
4882 | JP | Professional, scientific and te… |
|
PExA AB
Develops non-invasive technology for respiratory medicine b…
|
PEXA B | SE | Professional, scientific and te… |
|
PharmaResources (Shanghai) Co., Ltd.
Integrated CRO and CDMO for small molecule drug discovery a…
|
301230 | CN | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd
Delivers integrated R&D and manufacturing across the entire…
|
3759 | HK | Professional, scientific and te… |
|
Pharmaron Beijing Co., Ltd.
Integrated R&D provider for drug discovery, development, an…
|
300759 | CN | Professional, scientific and te… |
|
Pharos iBio Co., Ltd.
Clinical-stage biotech using AI to develop therapies for ra…
|
388870 | KR | Professional, scientific and te… |
IMMUNIC, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/10196/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=10196 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=10196 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=10196 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 10196}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMMUNIC, INC. (id: 10196)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.